Variability in vancomycin use in newborn intensive care units determined from data in an electronic medical record

Infection Control and Hospital Epidemiology

Volumn 29, Issue 7, 2008, Pages 667-670

  Arnold, Cody ^a,b,c   Clark, Reese ^c   Bosco, Jaclyn ^b,d   Shoemaker, Craig ^a   Spitzer, Alan R ^c  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR HEALTH CARE SYSTEM   (United States)

^c Pediatrix Obstetrix Center for Research and Education   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAFCILLIN; OXACILLIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG USE; ELECTRONIC MEDICAL RECORD; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; VERY LOW BIRTH WEIGHT;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; NAFCILLIN; OXACILLIN; VANCOMYCIN;

EID: 47549103307     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/588589     Document Type: Article

References (12)

1. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(Pt 1):285-291.
2. Clark R, Powers R, White R, Bloom B, Sanchez P, Benjamin DK Jr. Nosocomial infection in the NICU: a medical complication or unavoidable problem? J Perinatol 2004;24:382-388.
3. Krediet TG, Jones ME, Gerards LJ, Fleer A. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates. Pediatrics 1999;103:E29.
4. Rubin LG, Sanchez PJ, Siegel J, Levine G, Saiman L, Jarvis WR. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics 2002;110:e42.
5. Blayney MP, Al Madani M. Coagulase-negative staphylococcal infections in a neonatal intensive care unit: in vivo response to cloxacillin Paediatr Child Health 2006;11:659-663.
6. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000;106:1387-1390.
7. Lam JPH, Mitchell SJ, Gore C. Selective use of vancomycin for empirical treatment of neonatal sepsis: effects on clinical outcome and glycopeptide usage. Arch Dis Child 2001;84(Suppl 1):A10-A68.
8. Lawrence SL, Roth V, Slinger R, Toye B, Gaboury I, Lemyre B. Cloxacillin versus vancomycin for presumed late-onset sepsis in the neonatal intensive care unit and the impact on outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatr 2005;5:49.
9. Benjamin DK, DeLong E, Cotten CM, Garges HP, Steinbach WJ, Clark RH. Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J Perinatol 2004;24:175-180.
10. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004;39:1460-1466.
11. Healy CM, Palazzi DL, Edwards MS, Campbell JR, Baker CJ. Features of invasive staphylococcal disease in neonates. Pediatrics 2004;114:953-961.
12. Iezzoni LI. Risk Adjustment for Measuring Health Care Outcomes. Ann Arbor, MI: Health Administration Press; 1994.